Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLsBernhard Frankenberger, Heike Pohla, Elfriede Noessner, et al.
Blood|July 10, 2009
Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional aviditySusanne Wilde, Daniel Sommermeyer, Bernhard Frankenberger, et al.
Blood|February 29, 2012
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivoStefani Spranger, Irmela Jeremias, Susanne Wilde, et al.
Human Gene Therapy|October 1, 2009
Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinomaAlexander Buchner, Heike Pohla, Gerald Willimsky, et al.
World Journal of Urology|July 6, 2005
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cellsBernhard Frankenberger, Sybille Regn, Christiane Geiger, et al.
Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.
Molecular Medicine (Cambridge, Mass.)|December 28, 2012
High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccinationHeike Pohla, Alexander Buchner, Birgit Stadlbauer, et al.
Pageof 3